Clinical Trials Browser

Phase 2 × Lymphoma, Non-Hodgkin × Topotecan × Clear all

NCT00038545 2018-10-30

A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma

Phase 2 Completed

25 enrolled

Lymphoid

Aggression, Lymphoma, Lymphoma, Non-Hodgkin

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

Phase 2 Completed

10 enrolled

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

NCT00006373 2013-06-04

Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

Phase 2 Completed

27 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell